TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
VKTX

Viking Therapeutics Inc

Healthcare · Biotechnology

40.90$ +35.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Viking Therapeutics Inc (VKTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 716 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VKTX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
3.0 15 15 22 302 284 257 211 169 368 908 716
0.8 15 14 22 302 284 256 211 167 367 907 716
0.8 0.8 3.1 9.0 25 8.4 29 26 37 56 27 166
0.8 14 13 21 302 276 248 202 155 362 903 706
0.0 0.0 0.0
0.0 0.0 0.0 0.6 0.3 0.0 1.4
0.0 0.0 0.0
0.0 0.0 0.0
25 6.7 6.5 8.7 4.6 7.1 12 8.8 23 20 28 77
23 2.0 6.5 8.7 4.6 6.8 12 8.8 22 19 27 77
0.3 2.2 3.3 3.5 0.3 0.3 0.0 0.3 0.3 0.5 0.1
1.8 0.6 1.2 1.5 1.0 2.4 4.0 1.4 8.5 7.5 9.8 53
1.3 2.2 0.0 0.0
-22 8.7 8.0 13 298 277 244 202 145 348 880 639
-22 -46 -60 -81 -103 -129 -168 -223 -292 -378 -488 -848
4.3 6.4 16 26 58 72 73 77 77 94 109 113

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?